日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Shared PRAME epitopes are T-cell targets in NUT carcinoma

共享的PRAME表位是NUT癌中T细胞的靶点。

Jensen, Jeffrey L; Peterson, Sara K; Sambade, Maria J; Alley, Jessica R; Yu, Shawn; Kinjo, Tomoaki; Bennett, Sarah N; Vensko, Steven P 2nd; Shabrang, Mitra; Debetta, Johnathan D; Geyer, Julie K; Price, Brandon A; Nickel, Kwangok P; Kimple, Randall J; Kotecha, Rishi S; Herring, Laura E; Davis, Ian J; Wang, Jeremy R; French, Christopher A; Kuhlman, Brian; Weiss, Jared M; Rubinsteyn, Alex; Vincent, Benjamin G

Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases

乳腺癌脑转移独特微环境的检查及其预后意义

Sambade, Maria J; Prince, Grace; Deal, Allison M; Trembath, Dimitri; McKee, Megan; Garrett, Amy; Keith, Kevin; Ramirez, Juanita; Midkiff, Bentley; Blackwell, Kimberly; Sammons, Sarah; Leone, Jose Pablo; Brufsky, Adam; Morikawa, Aki; Brogi, Edi; Seidman, Andrew; Ewend, Matthew; Carey, Lisa A; Moschos, Stergios J; Hamilton, Ronald L; Vincent, Benjamin; Anders, Carey

LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

LCCC 1025:一项评估依维莫司、曲妥珠单抗和长春瑞滨联合治疗进展性 HER2 阳性乳腺癌脑转移的 II 期研究

Van Swearingen, Amanda E D; Siegel, Marni B; Deal, Allison M; Sambade, Maria J; Hoyle, Alan; Hayes, D Neil; Jo, Heejoon; Little, Paul; Dees, Elizabeth Claire; Muss, Hyman; Jolly, Trevor; Zagar, Timothy M; Patel, Nirali; Miller, C Ryan; Parker, Joel S; Smith, J Keith; Fisher, Julie; Shah, Nikita; Nabell, Lisle; Nanda, Rita; Dillon, Patrick; Abramson, Vandana; Carey, Lisa A; Anders, Carey K

Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.

MEK1/2 和 PI3K 或 PDGFR 的联合激酶抑制剂对颅内三阴性乳腺癌有效

Van Swearingen Amanda E D, Sambade Maria J, Siegel Marni B, Sud Shivani, McNeill Robert S, Bevill Samantha M, Chen Xin, Bash Ryan E, Mounsey Louisa, Golitz Brian T, Santos Charlene, Deal Allison, Parker Joel S, Rashid Naim, Miller C Ryan, Johnson Gary L, Anders Carey K

Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer

卡铂单药及联合ABT888治疗BRCA突变型和BRCA野生型三阴性乳腺癌颅内小鼠模型的疗效

Karginova, Olga; Siegel, Marni B; Van Swearingen, Amanda E D; Deal, Allison M; Adamo, Barbara; Sambade, Maria J; Bazyar, Soha; Nikolaishvili-Feinberg, Nana; Bash, Ryan; O'Neal, Sara; Sandison, Katie; Parker, Joel S; Santos, Charlene; Darr, David; Zamboni, William; Lee, Yueh Z; Miller, C Ryan; Anders, Carey K

Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts

拉帕替尼联合放射治疗可减少HER2+和基底样/EGFR+乳腺肿瘤异种移植模型中的肿瘤复发。

Sambade, Maria J; Kimple, Randall J; Camp, J Terese; Peters, Eldon; Livasy, Chad A; Sartor, Carolyn I; Shields, Janiel M

Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK.

拉帕替尼介导的乳腺癌细胞放射增敏机制主要是通过抑制 Raf>MEK>ERK 丝裂原活化蛋白激酶级联反应,而拉帕替尼耐药细胞的放射增敏作用则通过直接抑制 MEK 来恢复

Sambade Maria J, Camp J Terese, Kimple Randall J, Sartor Carolyn I, Shields Janiel M